Stem Cell Therapeutic Potential in Poor Ovarian Reserve and Premature Ovarian Insufficiency

Stem cells are native healers that comprise all of our body’s tissues and organs, have the power to transform into any cell they come into contact with, divide indefinitely, and regenerate and heal our entire body. As a result, it can be used to treat infertility in women.

There is no known treatment for ovarian reserve enhancement. In vitro fertilization (IVF) is the most common treatment for women with decreased ovarian reserves. Stem cell technologies have the potential to treat diminished ovarian reserve and premature ovarian insufficiency. The stem cell could massively increase the overall female fertility level by facilitating ovaries regeneration and enhancing poor ovarian reserve. Furthermore, it can also repair the tissues of the uterus and help the organ to produce healthy cells in a proper manner. This way, the women can get rid of their infertile state and pave the path of motherhood.

Endometriosis, tube or uterine structural problems, adhesions, and obstructions, all require gynecologic diagnosis and treatment. Other conditions that cause infertility, such as menstruation and ovulation abnormalities, polycystic ovarian syndrome, and menopause, can be treated with stem cells. If all endocrinological therapies are monitored effectively, the success rate for raising the quality and/or the number of eggs in the ovary is 67% or higher, depending on the individual’s condition.

Speaker: Dr Bakshi  Dr Bakshi is the chairperson at RISAA IVF and the founder of ADIVA Group of Hospitals. Dr Bakshi was awarded a WHO fellowship in Gynae Oncology from AIIMS, Delhi Senior Consultant Infertility Specialist & Endoscopy Surgeon. She is also the chair faculty at the Institute of Reproduction Fertility Training, Delhi.

She has various research projects funded by extramural agencies like ICMR, DST and DBT, is a member of many national and international societies and has been part of organising committees for various workshops and conferences.

Coordinator: Dr. Lipi Singh  Dr Lipi Singh, Stem Cell Expert & Clinical Scientist (Vice President, Advancells Group). Dr. Lipi Singh is the Vice President of Advancells Group in India. Dr Singh has over 18 years of expertise in the field of Stem Cell Biology and Regenerative Medicine, accomplished her postdoctoral research in Stem Cell Biology in 2011 at the City of Hope National Medical Center & Beckman Research Center, California, USA. She received an esteemed postdoctoral fellowship from the “California Institute of Regenerative Medicine, USA” for her work on pancreatic stem cells for replacement therapy of Type I Diabetes. She is also an active member (Clinical Fellow) of the American Academy of Anti-Aging Medicine in Florida, USA. She received her PhD in Pancreatology from the Post Graduate Institute of Medical Education and Research (PGIMER) in Chandigarh, India.

She has extensive experience in stem cell therapy, as well as product development and technology. The company successfully identified and purified hematopoietic and non-hematopoietic stem cells from a variety of sources, and banked them for future therapeutic purposes, under her leadership. She has a broad background in GMP-based cell production, as well as Quality Assurance and Regulatory Affairs in stem cell therapeutics and clinical studies. Her contributions in stem cell processing, banking, research, and therapies have garnered her national and international acclaim.

Presently, she is working with Advancells Group, India, to create a frontier of wellbeing through regenerative medicine, which is a pivotal necessity for health care worldwide. This encompasses overall health and endurance, as well as raising global awareness of “A new era of wellbeing through Regenerative Medicine”.

Webinar Date: 21st June 2022

Webinar Time: 4:00 P.M. TO 4:40 P.M. IST

 

Registration Link: https://www.advancells.com/stem-cell-therapeutic-potential-in-poor-ovarian-reserve-premature-ovarian-insufficiency/